Stephen A. Willey insider trades: BioMed Realty Trust (BMR) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Stephen reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 12, 2015 | BMR | ↓ Sell | 1,974 | $22.07 | $44K | Direct | Mar 16, 2015 (4d) |
| Sep 8, 2014 | BMR | ↓ Sell | 1,388 | $22.50 | $31K | Direct | Sep 8, 2014 (0d) |
| May 12, 2014 | BMR | ↓ Sell | 4,840 | $21.00 | $102K | Direct | May 13, 2014 (1d) |
| Mar 11, 2014 | BMR | ↓ Sell | 7,931 | $20.25 | $161K | Direct | Mar 12, 2014 (1d) |
| Mar 16, 2012 | BMR | ↓ Sell | 5,501 | $19.05 | $105K | Direct | Mar 19, 2012 (3d) |
| Mar 13, 2012 | BMR | ↓ Sell | 5,000 | $18.60 | $93K | Direct | Mar 15, 2012 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BMR insiders
Open-market trades in the last 12 months
About Stephen A. Willey's insider trades
Stephen A. Willey is Sr VP, Chief Accting Officer at BioMed Realty Trust (BMR). Since Mar 13, 2012, Stephen has reported no open-market purchases and 6 sales worth $535K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include shares withheld for taxes (11 filings), grants and awards (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BMR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.